Virtual Presentation

Chronic Lymphocytic Leukemia

Source: Clinical Issues and Future Directions in Hematologic Malignancies

Chronic Lymphocytic Leukemia


Faculty:

  • Michael J. Keating, MB BS

CME CREDIT INFORMATION

Release Date: 04/18/08

Expiration Date: 04/17/09


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Registered Nurses: 0.8 Nursing CE credit

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • List factors prognostic for outcomes in the treatment of chronic lymphocytic leukemia
  • Describe the use of alemtuzumab in combination chemotherapy regimens for patients with chronic lymphocytic leukemia
  • Discuss recent clinical trial data regarding the treatment of elderly patients with chronic lymphocytic leukemia
  • Explain clinical trial results regarding bendamustine in the clinical management of patients with chronic lymphocytic leukemia
  • Define monoclonal B-cell lymphocytosis and recall its treatment

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.